Antibiotic and antiseptic resistance: impact on public health

被引:87
作者
Levy, SB [1 ]
机构
[1] Tufts Univ, Sch Med, Ctr Adapt Genet & Drug Resistance, Boston, MA 02111 USA
关键词
antibiotics; antiseptics; public health;
D O I
10.1097/00006454-200010001-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
More and more we are moving patients from hospitals to homes for continued treatment. Vancomycin and triclosan were used for 30 years before any resistance emerged, because their applications were strictly limited. Today, after greatly increased use, resistance to both antibiotics and antibacterials has appeared. Of importance there are genetic links between resistance to antibiotics and to antibacterials. Health professionals and the public need to be educated about the rational use of drugs that affect the microbial world. The Alliance for the Prudent Use of Antibiotics, an international organization established in 1981 with members in more than 100 countries, has adopted education as its prime mission. Via its web site (www.apua.org) and linked information on reservoirs of antibiotic resistance (ROAR) among nonpathogenic bacteria, it reaches both providers and consumers. The message is simple: bacteria are needed for our survival. The vast majority of bacteria perform important functions that are crucial for our lives. Prudent use of both antibiotics and antibacterials must be championed to achieve and maintain the balanced microbial environment in which we have entered and evolved.
引用
收藏
页码:S120 / S122
页数:3
相关论文
共 16 条
[1]   Increase in resistance of methicillin-resistant Staphylococcus aureus to β-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals [J].
Akimitsu, N ;
Hamamoto, H ;
Inoue, R ;
Shoji, M ;
Akamine, A ;
Takemori, K ;
Hamasaki, N ;
Sekimizu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :3042-3043
[2]   Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon [J].
Alekshun, MN ;
Levy, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2067-2075
[3]  
[Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P707
[4]   Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin [J].
Ariza, J ;
Pujol, M ;
Cabo, J ;
Peña, C ;
Fernández, N ;
Liñares, J ;
Ayats, J ;
Gudiol, F .
LANCET, 1999, 353 (9164) :1587-1588
[5]  
Halsey NA, 1997, PEDIATRICS, V99, P289, DOI 10.1542/peds.99.2.289
[6]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[7]   Multidrug resistance - A sign of the times [J].
Levy, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (19) :1376-1378
[8]   The challenge of antibiotic resistance [J].
Levy, SB .
SCIENTIFIC AMERICAN, 1998, 278 (03) :46-53
[9]  
Levy SB., 1992, The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle
[10]   Vancomycin-resistant enterococci: recent advances in genetics, epidemiology and therapeutic options [J].
Malathum, K ;
Murray, BE .
DRUG RESISTANCE UPDATES, 1999, 2 (04) :224-243